Zevra Therapeutics (ZVRA) Non-Current Deferred Tax Liability (2014 - 2020)
Zevra Therapeutics (ZVRA) posted Non-Current Deferred Tax Liability of $18000.0 for Q4 2020, down 96.67% on a QoQ basis from $540000.0 in Q4 2019, and down 96.67% year-over-year from $540000.0 in Q1 2020.
Zevra Therapeutics (ZVRA) Non-Current Deferred Tax Liability (2014 - 2020) Analysis & Trends
Zevra Therapeutics' Non-Current Deferred Tax Liability history runs 7 years deep, the most recent figure standing at $18000.0 for Q4 2020.
- Quarterly Non-Current Deferred Tax Liability fell 96.67% year-over-year to $18000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $18000.0 (down 96.67% YoY) and the FY2020 annual result came in at $18000.0, down 96.67% from the prior year.
- Non-Current Deferred Tax Liability was $18000.0 for Q4 2020 at Zevra Therapeutics, down from $540000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $540000.0 in Q4 2019 and bottomed at $10000.0 in Q4 2018.
- A 5-year average of $183400.0 and a median of $89000.0 in 2016 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2019 — Non-Current Deferred Tax Liability jumped 5300.0% — and 2020, when it tumbled 96.67%.
- Zevra Therapeutics' Non-Current Deferred Tax Liability stood at $89000.0 in 2016, then soared by 192.13% to $260000.0 in 2017, then tumbled by 96.15% to $10000.0 in 2018, then soared by 5300.0% to $540000.0 in 2019, then plunged by 96.67% to $18000.0 in 2020.
- Business Quant data shows ZVRA's Non-Current Deferred Tax Liability at $18000.0 in Q4 2020, $540000.0 in Q4 2019, and $10000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 18,000.00 |
| Dec 31, 2020 | 18,000.00 |
| Dec 31, 2019 | 540,000.00 |
| Dec 31, 2019 | 540,000.00 |
| Dec 31, 2018 | 10,000.00 |
| Dec 31, 2018 | 10,000.00 |
| Dec 31, 2017 | 260,000.00 |
| Dec 31, 2017 | 260,000.00 |
| Dec 31, 2016 | 89,000.00 |
| Dec 31, 2016 | 89,000.00 |
| Dec 31, 2015 | 80,000.00 |
| Dec 31, 2015 | 80,000.00 |
| Dec 31, 2014 | 170,000.00 |
| Dec 31, 2014 | 170,000.00 |